KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Minority Interest: 2010-2013

Historic Minority Interest for Emergent BioSolutions (EBS) over the last 4 years, with Dec 2013 value amounting to -$453,000.

  • Emergent BioSolutions' Minority Interest fell 158.83% to -$453,000 in Q4 2013 from the same period last year, while for Dec 2013 it was -$453,000, marking a year-over-year decrease of 158.83%. This contributed to the annual value of -$453,000 for FY2013, which is 158.83% down from last year.
  • Per Emergent BioSolutions' latest filing, its Minority Interest stood at -$453,000 for FY2013, which was down 158.83% from $770,000 recorded in FY2012.
  • Over the past 5 years, Emergent BioSolutions' Minority Interest peaked at $4.1 million during FY2010, and registered a low of -$453,000 during FY2013.
  • For the 3-year period, Emergent BioSolutions' Minority Interest averaged around $932,667, with its median value being $770,000 (2012).
  • Data for Emergent BioSolutions' Minority Interest shows a maximum YoY crashed of 158.83% (in 2013) over the last 5 years.
  • Emergent BioSolutions' Minority Interest (Yearly) stood at $4.1 million in 2010, then tumbled by 39.44% to $2.5 million in 2011, then slumped by 68.96% to $770,000 in 2012, then tumbled by 158.83% to -$453,000 in 2013.